COMP <GO>
PRGS vs CNXC // EV/EBITDA & P/E VALUATION
Progress Software Corporation (NASDAQ) VS. Concentrix Corporation (NASDAQ) • 15-METRIC TALLY: PRGS 7
— CNXC 2
■ METRIC PARITY
LAST: $44.93 (+1.06%) • MKT CAP: $1.84B
valuation
17.6x
LAST: $30.34 (-0.62%) • MKT CAP: $1.85B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PRGS VS. CNXC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PRGS | CNXC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 80.80% | 35.00% | +45.80 | PRGS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.50% | -10.40% | +18.90 | PRGS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 17.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.50% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 15.70% | -9.30% | +25.00 | PRGS | /operating-margins <GO> |
| Net Profit Margin | 7.50% | -13.00% | +20.50 | PRGS | /net-margins <GO> |
| Revenue Growth (YoY) | 29.80% | 2.20% | +27.60 | PRGS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.04% | 4.83% | -4.79 | CNXC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.85 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 5/9 | +2.00 | PRGS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.9 | 55.1 | +6.80 | PRGS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 21.1x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.84B | $1.85B | -$17.5M | CNXC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PRGS REV | CNXC REV | PRGS GROSS % | CNXC GROSS % | PRGS FCF | CNXC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $977.8M | $9.83B | 80.8% | 35.0% | $229.5M | $572.5M |
| FY 2024 | $753.4M | $9.62B | 82.7% | 35.9% | $206.3M | $428.7M |
| FY 2023 | $694.4M | $7.11B | — | — | $173.9M | $678.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PRGS // BETA —
CNXC // BETA —